about
Human glutamate cysteine ligase gene regulation through the electrophile response elementThe Effects of Sequence Variation on Genome-wide NRF2 Binding--New Target Genes and Regulatory SNPsGeneration and biological activities of oxidized phospholipidsNovel keto-phospholipids are generated by monocytes and macrophages, detected in cystic fibrosis, and activate peroxisome proliferator-activated receptor-γ.Redox regulation of antioxidants, autophagy, and the response to stress: implications for electrophile therapeutics.Mechanisms of the pro- and anti-oxidant actions of nitric oxide in atherosclerosis.Electrophilic nitro-fatty acids activate NRF2 by a KEAP1 cysteine 151-independent mechanism.Mitochondria, nitric oxide, and cardiovascular dysfunction.Cytoprotection against oxidative stress and the regulation of glutathione synthesis.MicroRNA profiling of pericardial fluid samples from patients with heart failureEnhanced polyamine catabolism alters homeostatic control of white adipose tissue mass, energy expenditure, and glucose metabolism.Pyrrolidine dithiocarbamate activates the Nrf2 pathway in astrocytes.Antioxidant gene therapy for cardiovascular disease: current status and future perspectives.Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease.Nrf2-dependent and -independent responses to nitro-fatty acids in human endothelial cells: identification of heat shock response as the major pathway activated by nitro-oleic acid.Lipid accumulation, lipid oxidation, and low plasma levels of acquired antibodies against oxidized lipids associate with degeneration and rupture of the intracranial aneurysm wall.Regulation of Nrf2-dependent gene expression by 15-deoxy-Delta12,14-prostaglandin J2.Role of the Keap1-Nrf2 pathway in cancer.Heme oxygenase 1 is induced by miR-155 via reduced BACH1 translation in endothelial cells.Applications of the Keap1-Nrf2 system for gene and cell therapy.Dysregulation of the Keap1-Nrf2 pathway in cancer.Nitro-oleic acid regulates endothelin signaling in human endothelial cells.Hemin and Cobalt Protoporphyrin Inhibit NLRP3 Inflammasome Activation by Enhancing Autophagy: A Novel Mechanism of Inflammasome Regulation.Keap1 as the redox sensor of the antioxidant response.Pro-nociceptive migraine mediator CGRP provides neuroprotection of sensory, cortical and cerebellar neurons via multi-kinase signaling.Prostaglandin 15d-PGJ(2) inhibits androgen receptor signaling in prostate cancer cells.Oxidative stress-regulated lentiviral TK/GCV gene therapy for lung cancer treatment.Oxidative stress-inducible lentiviral vectors for gene therapy.Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2.Human cystathionine gamma-lyase: developmental and in vitro expression of two isoforms.MicroRNA Profiling Reveals Distinct Profiles for Tissue-Derived and Cultured Endothelial Cells.Electrophilic lipid mediator 15-deoxy-Δ12,14-prostaglandin j2 modifies glucocorticoid signaling via receptor SUMOylation.Does Nrf2 gene transfer facilitate recovery after contusion spinal cord injury?Sulforaphane inhibits endothelial lipase expression through NF-κB in endothelial cells.Cytochrome P450 2A5 constitutive expression and induction by heavy metals is dependent on redox-sensitive transcription factor Nrf2 in liver.The absence of macrophage Nrf2 promotes early atherogenesis.Activation of c-Jun N-terminal kinase and apoptosis in endothelial cells mediated by endogenous generation of hydrogen peroxide.HIF-1 induction attenuates Nrf2-dependent IL-8 expression in human endothelial cells.Extracellular superoxide dismutase accelerates endothelial recovery and inhibits in-stent restenosis in stented atherosclerotic Watanabe heritable hyperlipidemic rabbit aorta.NRF2 regulates endothelial glycolysis and proliferation with miR-93 and mediates the effects of oxidized phospholipids on endothelial activation.
P50
Q28284915-67F1AFEA-2E8A-4559-81CF-BBF8CC1AA0F0Q28388133-640F14B3-2912-41BE-BFBD-84706A4C97FCQ28389691-783E644E-A9C8-4336-9988-0F1778324413Q30573092-1277C5CF-2E36-453A-ACC1-E3EBFF1C24F6Q33702016-65547CC9-269D-4439-9401-29E5769667D1Q34017492-4A795715-A7EC-4BAE-A7AD-1AF6C66559C6Q34800018-6501CE93-2CE2-498B-8FFA-4A05D517879DQ35006528-DAFD1B15-AD12-486C-ACAD-0273651A0AEAQ35129259-6E7DDBB4-1EF8-474C-8698-B66C6D996424Q35170871-02D75FEC-B4D9-4B4B-AB09-82184F38C421Q35948168-03E873FD-B9BB-4EDA-B38D-ADD948355F11Q36622182-F0EF708F-0389-4DBC-B184-C5291737A15BQ37143726-1952045D-BBAD-4B09-9D53-65CC299EFD78Q37364086-5C917E89-966A-4954-824F-11E2EA9A3D6FQ37446099-49A7EDF7-1B7C-4D55-B4E9-80D34664C6DBQ37484799-01D63208-54D4-4D1A-BB38-6BD35CE47BC3Q37539108-ED3F5690-3D02-41C8-9528-D574B241EEEFQ38224114-00386CED-D2C0-4482-9D78-664A5AB8BD95Q38331289-571653C0-60AF-45C2-BFF9-F22E7C9F7B8CQ38545417-F0199131-2469-4F9E-8E6F-52F3E70BB08BQ38628908-055ED54A-B14E-49A5-B860-7A1AB7C15F78Q38639796-021BEB54-C0B0-4BE4-92FC-968B8954E689Q38744481-2AA91C70-324A-4C56-8BA5-98613F7BD09DQ38987910-137E23F1-765B-47EA-BF21-A16979DB5E85Q39155577-B878A744-8F6F-4562-B971-1353A1A37729Q39236149-C2B5B2F2-C822-48EF-B424-427A235035D3Q39264777-F3D4E68A-296D-4BF1-BB91-6DC55E6CE885Q39986624-29842C10-9797-49BB-9918-87A8DF2E193BQ40025586-547C9D97-F0DF-44F1-A086-84AF59C1BD98Q40892341-998F5C54-93C2-4D60-AFD6-4E039DC97C73Q41478397-EF282872-EDC8-4704-B19B-6857B7202963Q42005821-2D66CA79-84E3-48E4-95E3-487DBA171FC8Q42284843-246F5649-B423-45F2-9442-AC8E6C533BA4Q42945166-FEE2992B-942C-4658-95AB-5AA5B5875573Q43094093-3FF352A4-E1B6-41CC-9DB1-0E5FE615E423Q43901244-13CE27DB-AC4D-4002-9423-657B72B52336Q44008176-17D6C767-085E-4F1E-9623-E801D21B2A10Q44589810-7FF93123-7F8A-4AF2-87B9-18E9657D91B2Q45873445-F58C7D1C-E907-4B64-A9E3-7BE681DD1760Q46257036-BB13C9B3-E65A-4613-B678-F1815754FBF4
P50
description
researcher ORCID ID = 0000-0002-6575-2137
@en
wetenschapper
@nl
name
Anna-Liisa Levonen
@ast
Anna-Liisa Levonen
@en
Anna-Liisa Levonen
@es
Anna-Liisa Levonen
@nl
type
label
Anna-Liisa Levonen
@ast
Anna-Liisa Levonen
@en
Anna-Liisa Levonen
@es
Anna-Liisa Levonen
@nl
prefLabel
Anna-Liisa Levonen
@ast
Anna-Liisa Levonen
@en
Anna-Liisa Levonen
@es
Anna-Liisa Levonen
@nl
P1153
6602628955
P21
P31
P496
0000-0002-6575-2137